On September 2, 2021 Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, reported plans to participate in the upcoming virtual H.C. Wainwright Global Investment Conference (Press release, Pulse Biosciences, SEP 2, 2021, View Source [SID1234587239]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management is scheduled to participate and hold one-on-one meetings Tuesday, September 14, 2021. A presentation webcast will be available at the start of the conference on Monday, September 13, 2021, at 7:00 am ET. Interested parties may access the on-demand webcast at the same time on the "Investors" section of the Company’s website at www.pulsebiosciences.com.